Colossal Biosciences Delayed Mammoth Revival Project

The company adjusted its timeline to the early 2030s after discovering increased genetic complexity.

Updated on Sept. 26, 2026 in Life Sciences

A stainless-steel cryogenic freezer unit in a clean, brightly lit modern science laboratory. — Colossal Biosciences has pushed its goal for reviving the woolly mammoth to the early 2030s, citing the need for additional genetic edits. AI Illustration. Upload story photo >

Live Poll

Do you support the use of gene-editing technology to bring extinct species back to life?

Colossal Biosciences has pushed back its goal to revive the woolly mammoth to the early 2030s. The shift follows a determination that significantly more gene edits are required than researchers originally anticipated.

Why it matters

This delay highlights the scientific challenges of de-extinction, as researchers struggle to replicate the specific traits of the species using elephant nuclei.

Researchers have scaled the required gene edits from 60 to 150 to successfully engineer a mammoth embryo. To date, the company has successfully created a family of 38 woolly mice using mammoth genetic coding.

The players

Colossal Biosciences

This Dallas-based company utilizes advanced genetic engineering and CRISPR technology to focus on species de-extinction efforts.

The details

Based in Dallas, the team uses AI and CRISPR technology to modify elephant DNA, leveraging information from remains discovered in Siberia in 2018. The project has already successfully de-extincted the dire wolf in 2025 and identified specific genes that control mammoth ear size.

2018: Scientists discovered remains of a frozen mammoth in Siberia.
2024: The company previously forecast a four-year timeline for revival.
2025: Colossal Biosciences successfully de-extincted the dire wolf.
September 26, 2026: The company announced the official timeline delay.
Early 2030s: The firm now expects to revive the woolly mammoth.

The Big Picture

This timeline adjustment follows the pattern established by the successful de-extinction of the dire wolf in 2025. It suggests that scaling genetic modifications for larger, more complex species requires more iterative research than early-stage trials.

The advancement of CRISPR and AI gene-editing techniques potentially accelerates the development of medical therapies and biotechnology applications. The project provides foundational insights into genetic engineering that could influence agricultural yields and conservation efforts.

The takeaway

De-extinction efforts face significant technical hurdles when moving from small-scale models to complex megafauna. Readers should view these timelines as moving targets influenced by the inherent difficulty of modern genomic manipulation.